You are here

  • Home
  • Archive
  • Volume 67, Issue 5
  • miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis

Article info

Article menu

Download PDFPDF

XML
Hepatology
Original article
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis

Authors

  • Nicolaas Van Renne Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Armando Andres Roca Suarez Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Francois H T Duong Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Claire Gondeau Inserm, U1183, Institut de Médecine Régénératrice et Biothérapie, Université de Montpellier, Montpellier, France Département d'Hépato-gastro-entérologie A, Hôpital Saint Eloi, CHU Montpellier, Montpellier, France PubMed articlesGoogle scholar articles
  • Diego Calabrese Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Nelly Fontaine Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Amina Ababsa Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Simonetta Bandiera Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Tom Croonenborghs The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA Program in Translational NeuroPsychiatric Genomics, Brigham and Women's Hospital, Harvard Medical School, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Nathalie Pochet The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA Program in Translational NeuroPsychiatric Genomics, Brigham and Women's Hospital, Harvard Medical School, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Vito De Blasi Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France Pôle Hépato-digestif, Institut Hospitalo-universitaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Patrick Pessaux Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France Pôle Hépato-digestif, Institut Hospitalo-universitaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Tullio Piardi Department of General, Digestive and Endocrine Surgery, Hôpital Robert Debré, Centre Hospitalier Universitaire de Reims, Université de Reims Champagne-Ardenne, Reims, France PubMed articlesGoogle scholar articles
  • Daniele Sommacale Department of General, Digestive and Endocrine Surgery, Hôpital Robert Debré, Centre Hospitalier Universitaire de Reims, Université de Reims Champagne-Ardenne, Reims, France PubMed articlesGoogle scholar articles
  • Atsushi Ono Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan PubMed articlesGoogle scholar articles
  • Kazuaki Chayama Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan Laboratory for Digestive Diseases, RIKEN Center for Integrative Medical Sciences, The Institute of Physical and Chemical Research (RIKEN), Hiroshima, Japan Liver Research Project Center, Hiroshima University, Hiroshima, Japan PubMed articlesGoogle scholar articles
  • Masashi Fujita Laboratory for Genome Sequencing Analysis, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Hidewaki Nakagawa Laboratory for Genome Sequencing Analysis, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Yujin Hoshida Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articlesGoogle scholar articles
  • Mirjam B Zeisel Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Markus H Heim Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland PubMed articlesGoogle scholar articles
  • Thomas F Baumert Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France Pôle Hépato-digestif, Institut Hospitalo-universitaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Joachim Lupberger Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France Université de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Joachim Lupberger, Inserm U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, 3, rue Koeberlé, Strasbourg 67000, France; joachim.lupberger{at}unistra.fr
View Full Text

Citation

Van Renne N, Roca Suarez AA, Duong FHT, et al
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis
Gut 2018;67:953-962.

Publication history

  • Received May 19, 2016
  • Accepted January 12, 2017
  • First published February 3, 2017.
Online issue publication 
March 06, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/